Bolette Hartmann Selected Research

Gastrointestinal Hormones (Hormones, Gastrointestinal)

1/2022	Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg).
1/2017	Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
1/2015	GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass.
12/2003	Role of gastrointestinal hormones in postprandial reduction of bone resorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bolette Hartmann Research Topics

Disease

33	Type 2 Diabetes Mellitus (MODY) 10/2022 - 11/2012
26	Bone Resorption 01/2022 - 12/2003
16	Body Weight (Weight, Body) 01/2022 - 05/2002
15	Obesity 01/2022 - 04/2014
13	Insulin Resistance 03/2022 - 09/2012
10	Overweight 05/2022 - 01/2019
10	Weight Loss (Weight Reduction) 01/2022 - 08/2015
10	Short Bowel Syndrome 01/2021 - 07/2007
9	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2015
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 08/2015
7	Hyperglycemia 01/2022 - 09/2015
6	Inflammation (Inflammations) 02/2021 - 10/2013
5	Neoplasms (Cancer) 01/2021 - 09/2007
5	Atrophy 05/2017 - 06/2004
4	Weight Gain 01/2022 - 10/2004
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 03/2018
4	Mucositis 01/2019 - 07/2012
4	Intestinal Failure 01/2018 - 09/2012
3	Glucose Intolerance 03/2022 - 04/2016
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2020
3	Osteoporosis 01/2021 - 02/2013
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Anorexia 01/2021 - 01/2019
2	Adenoma (Adenomas) 01/2021 - 11/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 01/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 09/2014
2	Morbid Obesity 12/2019 - 01/2015
2	Fatty Liver 01/2019 - 01/2019
2	Primitive Neuroectodermal Tumors (PNET) 01/2015 - 01/2015

Drug/Important Bio-Agent (IBA)

37	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2022 - 12/2003
34	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 11/2014
32	Glucagon (Glukagon)FDA Link 01/2022 - 02/2005
28	Hormones (Hormone)IBA 03/2022 - 12/2003
18	Peptides (Polypeptides)IBA 10/2022 - 09/2007
15	IncretinsIBA 03/2022 - 09/2012
15	Insulin (Novolin)FDA Link 01/2022 - 01/2015
14	Collagen Type I (Type I Collagen)IBA 01/2022 - 12/2003
8	gastric inhibitory polypeptide receptorIBA 01/2022 - 04/2016
7	Triglycerides (Triacylglycerol)IBA 05/2022 - 01/2018
7	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 12/2015
7	Liraglutide FDA Link 01/2021 - 11/2012
7	ProcollagenIBA 01/2021 - 08/2015
6	C-PeptideIBA 01/2022 - 05/2017
6	CarbohydratesIBA 01/2022 - 03/2018
6	CollagenIBA 01/2022 - 08/2015
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
5	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2020
5	C-Reactive ProteinIBA 01/2022 - 01/2019
5	Blood Glucose (Blood Sugar)IBA 02/2021 - 05/2002
5	Glucagon-Like Peptide 2IBA 01/2019 - 07/2007
4	Sitagliptin Phosphate (Januvia)FDA Link 10/2022 - 11/2012
4	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2022 - 01/2017
4	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2022 - 12/2003
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2020 - 01/2015
3	Glucagon-Like Peptides (Enteroglucagon)IBA 05/2022 - 12/2003
3	OsteocalcinIBA 01/2022 - 03/2007
3	Procollagen Type IIBA 01/2022 - 01/2021
3	Peptide YYIBA 01/2022 - 02/2005
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	gastric inhibitory polypeptide (3-30)-amideIBA 05/2021 - 01/2019
3	LipidsIBA 01/2021 - 01/2019
3	Parathyroid Hormone (Parathormone)IBA 01/2021 - 01/2008
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2020 - 08/2014
2	Lipoproteins (Lipoprotein)IBA 05/2022 - 01/2020
2	oxidized low density lipoproteinIBA 01/2022 - 03/2018
2	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 01/2022 - 01/2017
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2021
2	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2022 - 01/2022
2	glimepiride (Amarel)FDA LinkGeneric 01/2022 - 11/2020
2	Exenatide (Byetta)FDA Link 01/2022 - 01/2018
2	LinagliptinIBA 01/2022 - 11/2020
2	PrebioticsIBA 10/2021 - 09/2012
2	Interleukin-6 (Interleukin 6)IBA 02/2021 - 01/2019
2	Whey ProteinsIBA 01/2021 - 01/2021
2	Glucagon Receptors (Glucagon Receptor)IBA 01/2021 - 12/2015
2	EnzymesIBA 01/2021 - 12/2016
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2019 - 12/2016
2	LeptinIBA 01/2019 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 03/2018
2	CholesterolIBA 01/2019 - 03/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 12/2013
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 07/2012
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2017 - 01/2015
2	OxyntomodulinIBA 05/2016 - 12/2015
2	Proglucagon (Glucagon Precursors)IBA 12/2015 - 01/2015

Therapy/Procedure

12	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 09/2014
12	Therapeutics 01/2022 - 10/2010
5	Drug Therapy (Chemotherapy) 01/2019 - 07/2012
4	Subcutaneous Injections 01/2022 - 12/2003
4	Parenteral Nutrition 05/2017 - 06/2004
4	Enteral Nutrition (Feeding, Tube) 05/2017 - 09/2012
3	Gastrectomy 01/2022 - 07/2007
3	Jejunostomy 01/2021 - 01/2008
3	Total Parenteral Nutrition 05/2017 - 06/2004
2	Glycemic Control 10/2022 - 01/2019
2	High-Protein Diet 01/2022 - 01/2022
2	Oral Administration 01/2021 - 01/2018
2	Bariatric Surgery 01/2020 - 01/2015
2	Intravenous Infusions 01/2018 - 01/2017